| 2004 | NeuroRx | Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. |
| 2004 | Neurology | Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. |
| 2002 | Neurology | Regional and progressive thinning of the cortical ribbon in Huntington's disease. |
| 2004 | Cereb Cortex | Thinning of the cerebral cortex in aging. |
| 1999 | Neurobiol Aging | Sex differences in prefrontal volume with aging and Alzheimer's disease. |
| 2002 | Cereb Cortex | Greater orbital prefrontal volume selectively predicts worse working memory performance in older adults. |
| 2001 | Arch Neurol | Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. |
| 2010 | Neurobiol Aging | Automated MRI measures predict progression to Alzheimer's disease. |
| 2009 | Brain | Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. |
| 2010 | Arch Neurol | Genetic variation and neuroimaging measures in Alzheimer disease. |
| 2009 | J Neurosci | Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease. |
| 2010 | Neuroimage | Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". |
| 2009 | Neuroimage | Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. |
| 2008 | Ann NY Acad Sci | Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease? |
| 2009 | Neuroimage | Regional white matter volume differences in nondemented aging and Alzheimer's disease. |
| 2009 | Cereb Cortex | The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia... |
| 2010 | Neurobiol Aging | White matter pathology isolates the hippocampal formation in Alzheimer's disease. |
| 2001 | Neurologist | 10 most commonly asked questions about Huntington's disease. |
| 2008 | Brain | Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. |
| 2006 | Stroke | White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. |
| 2009 | Neurobiol Aging | Consistent neuroanatomical age-related volume differences across multiple samples. |
| 2006 | Mov Disord | Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. |
| 2005 | Ann NY Acad Sci | Age-related changes in prefrontal white matter measured by diffusion tensor imaging. |
| 2005 | Neurology | Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. |
| 1999 | Arch Neurol | Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. |
| 2008 | Neuroimage | The relationship between diffusion tensor imaging and volumetry as measures of white matter properties. |
| 1997 | Neurobiol Aging | Sex differences in the corpus callosum with aging. |
| 2008 | Nat Methods | Linking SNPs to CAG repeat length in Huntington's disease patients. |
| 2008 | Neurotherapeutics | Neuroprotection for Huntington's disease: ready, set, slow. |
| 2001 | Expert Rev Neurother | Neuroprotective therapy for Huntington's disease: new prospects and challenges. |
| 2005 | Pharmacol Ther | The therapeutic role of creatine in Huntington's disease. |
| 2005 | Proc Natl Acad Sci USA | Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. |
| 2001 | Neurology | Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. |
| 1999 | Mov Disord | Riluzole therapy in Huntington's disease (HD). |
| 1998 | Neurology | 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. |